Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Raute receives order of EUR 44.6 million to France

RAUTE CORPORATION PRESS RELEASE May 10, 2023 at 09:00 a.m. Raute receives order of EUR 44.6 million to France Raute Corporation has signed a contract worth EUR 44.6 million with the THEBAULT Group, France for the technology delivery of a new greenfield LVL (Laminated Veneer Lumber) production plant. Following the terms of the contract, the project has become effective by the signing of a delivery contract. This project was earlier referred to in the stock exchange release dated March 9, 2023 (Raute plans directed share issue, rights issue, and junior loan support targeted growth

Vestas – Interim Financial Report, First Quarter 2023

Summary: Quarterly revenue of EUR 2.8bn with an EBIT margin before special items of 1.4 percent. Continued strong wind turbine backlog of EUR 19.7bn driven by higher order intake. Full-year guidance maintained. In the first quarter of 2023, Vestas generated revenue of EUR 2,829m – an increase of 14 percent compared to the year-earlier period. EBIT before special items amounted to EUR 40m, resulting in an EBIT margin before special items of 1.4 percent, compared to negative 13.2 percent in the first quarter of 2022. Free cash flow[1)] amounted to negative EUR 1,081m compared to

HC Andersen Capital Events 10/05: Meet the top management in BioPorto

HC Andersen Capital is hosting a digital event where you can meet and ask questions directly to the top management. It is free for all to attend.BioPorto - Presentation of Q1 2023BioPorto releases its Interim Report for the first quarter of 2023 on Wednesday, May 10th, and participates in a digital event hosted by HC Andersen Capital at 14:30 CEST where CEO Tony Paré and CFO Neil Goldman will present the report and highlights from the first quarter period followed by a Q&A session.  Disclaimer: HC Andersen Capital receives payment from BioPorto for a Digital IR/Corporate Visibility

Interim report Q1: Clear effects of cost reductions and positive cash flow but generally lower market activity hits the volumes

January-March 2023 • Net sales amounted to SEK 246 million (237). Net sales declined 4 percent organically. • The EVSE share of net sales increased to 39 percent (17) and amounted to SEK 96 million (37). • Adjusted EBITA declined to SEK 7 million (22), corresponding to amargin of 3.0 percent (9.3). • Net profit for the period amounted to SEK -18 million (profit: 11) and earnings per share after dilution amounted to SEK -0.35 (0.22). • Cash flow from operating activities amounted to SEK 36 million (-1). • CTEK carried out a rights issue of 350 SEK million in March that was

Storebrand Boligkreditt AS: Interim Report Q1 2023

Storebrand Boligkreditt AS is a wholly owned subsidiary of the listed company Storebrand ASA. For information about the Storebrand Group's Q1 2023 result and Balance sheet statement, please refer to the Storebrand Group Q1 2023 interim report. Storebrand Boligkreditt AS's interim report for Q1 2023 is attached.This information is subject of the disclosure requirements acc. to §5-12 vphl (Norwegian Securities Trading Act)

Storebrand Livsforsikring AS: Interim Report Q1 2023

Storebrand Livsforsikring AS is a wholly owned subsidiary of the listed company Storebrand ASA. For information about the Storebrand Group's Q1 2023 result and Balance sheet statement, please refer to the Storebrand Group Q1 2023 interim report. Storebrand Livsforsikring AS's interim report for Q1 2023 is attached.This information is subject of the disclosure requirements acc. to §5-12 vphl (Norwegian Securities Trading Act)

Lundbeck’s sales increased by 15% (+11% at constant exchange rates) to DKK 5 billion in the first quarter of 2023

Key highlights Lundbeck’s sales increased by 15% (+11% CER[1]) to DKK 5,044 million, with all regions growing and the U.S. and Europe contributing strongly · United States: DKK 2,337 million (+22%; +16% CER) · International Markets: DKK 1,499 million (+3%; +3% CER) · Europe: DKK 1,174 million (+15%; +14% CER) The growth of Lundbeck’s strategic brands grew further with an increase of 23% (+19% CER), reaching DKK 3,273 million, representing 65% of total revenue · Brintellix[®]/Trintellix[®]: DKK 1,077 million (+9%; +7% CER) · Rexulti[®]/Rxulti[®]: DKK 1,060 million (

HKScan’s profitability improved, but January-March EBIT slightly negative

HKScan Corporation, January-March Interim Report, 10 May 2023 at 8.30 a.m. EETHKScan’s Interim Report 1 January – 31 March 2023 January-March 2023  · HKScan’s net sales from continuing operations increased by 15.6 per cent to EUR 457.6 (395.9) million. During the review period, sales prices were significantly higher than in the comparison period as higher costs due to strong inflation had been passed on to sales prices during 2022. · The Group’s EBIT from continuing operations totalled EUR -0.1 (-4.4) million.  · The Group’s comparable EBIT from continuing operations was EUR -

Saga Pure: First quarter 2023 financial results

(Oslo, 10 May 2023) Saga Pure ASA (Saga Pure, OSE: SAGA) reported a net loss in the first quarter 2023 of NOK 81.7 million (Q1 2022: Profit NOK 53.6 million), corresponding to a return on equity of minus 8.2 percent year to date. The negative result in the first quarter is mainly driven by the share price development in legacy investment Horisont Energi AS. Saga Pure continues to implement the expanded investment mandate with a focus on capital discipline and selective investments.“The reported financial results in the first quarter of 2023 reflect the negative share price development in

Terveystalo Capital Markets Day 2023

Terveystalo hosts its Capital Markets Day today, 10 May 2023 in Helsinki at 10:00-14:30 EEST. The event will offer an update on Terveystalo’s current operating environment and strategy with the new operating model, as well as an update on the progress of the 2-year profit improvement program. The day will include presentations by Ville Iho, President, and CEO, Juuso Pajunen, CFO, and other management team members. The presentation materials will be available at the beginning of the event at: https://www.terveystalo.com/en/company/investors/capital-markets-day-2023.All the

Skanska signs 20,300 square meter lease agreement in the Centrum Poludnie office complex in Wroclaw, Poland

Skanska has signed a 10-year lease agreement with the American bank BNY Mellon for approximately 20,300 square meters and in addition 191 parking lots in the second phase of Centrum Poludnie office complex in Wroclaw, Poland. With this contract, all office space is leased, with the remaining space dedicated to amenity and retail uses, such as a kindergarten. In total, 93 percent of the building is now leased.BNY Mellon serves capital markets globally by providing comprehensive solutions for clients to manage and service their financial assets throughout the investment life cycle. Wroclaw

Notice to annual general meeting in Readly International AB (publ)

The shareholders are hereby called to the annual general meeting of Readly International AB (publ), 556912-9553, (the “Company”), to be held on Tuesday 13 June 2023 at 14:00 (CEST), at the Company's premises at Kungsgatan 17 in Stockholm. Entry and registration begin at 13:30 (CEST).The board of directors has decided, pursuant to the Company’s articles of association, that shareholders shall have the right to exercise their voting rights by postal voting. Shareholders may therefore choose to exercise their voting rights at the annual general meeting by attending in person, through a proxy

Wihlborgs starts the transformation of the historic Malmö Börshus

Malmö Börshus (Börshuset 1) is more than just a historic building and a symbol for trade and commerce in the city – it is also a central location through which some 50,000 people pass daily. Now Wihlborgs is starting a transformation that, after an extensive renovation, will showcase its character and history and at the same time open it up to become a more dynamic city space.Renovation of the facade and the interior are both starting in autumn 2023. The aim is to upgrade to a more modern and energy efficient standard, and to reinstate the original appearance of the Börshus, while also

Archer Limited: Strong first quarter financial performance

Hamilton, Bermuda (May 10, 2023) First Quarter 2023 Highlights · Revenue of $267 million, up 22% from the same quarter last year · Strong EBITDA of $25.2 million, up 55% from the same quarter last year · Strong cash management contributed to reduced NIBD · Integrated the P&A specialist Romar-Abrado during the quarter · Completed the acquisition of Baker Hughes’ UK coil tubing and pumping business · Completed the refinancing in April On the strong first quarter, Dag Skindlo, CEO of Archer, comments: “I am pleased to report strong financial results in the first

STOREBRAND ASA: Results for the 1st Quarter 2023

· Cash equivalent earnings[1] of NOK 757m and IFRS profit before amortisation and tax of NOK 1,157m in the quarter · Solvency II ratio 179% · All-time high assets under management amounting to NOK 1,111bn, up 9% in the quarter supported by NOK 18bn net inflow Storebrand continues to deliver very strong growth in all business areas – occupational pensions, asset management, and in the Norwegian retail market – despite another quarter with market turbulence where inflation remains high and central banks continue to raise rates. I'm proud to see that we have reached an all-time high

Sitowise's Interim Report January - March 2023: Strong quarter in a challenging market environment

Sitowise Group Plc, Interim Report, 1 January - 31 March 2023, 10 May 2023 at 8:30 am EEST This release is a summary of Sitowise Group’s financial statements release January–December 2022. The complete financial statements release is attached, and also available on the company’s website at www.sitowise.com/investors/reports-and-presentations January – March in brief · Net sales increased by 14% to EUR 56.0 (49.2) million. · Organic net sales grew by 4% (7%). · Adjusted EBITA was EUR 6.6 (5.2) million, or 11.8% (10.6%) of net sales. · Operating profit totaled EUR 5.5 (2.9)

Shaping next generation material handling for a smarter, safer and better world: Konecranes announces new financial targets

KONECRANES PLC INSIDE INFORMATION MAY 10, 2023 8:30 AM EEST   Shaping next generation material handling for a smarter, safer and better world: Konecranes announces new financial targets   Konecranes announces its refreshed purpose, ambition and financial targets for the coming years ahead of its Capital Markets Day which will be held today, May 10.   “The world is facing an increasingly acute challenge to provide materials and goods that are essential for people while preserving scarce resources and limiting emissions. Businesses have a central role to play in solving this

Eevia Health Plc exhibiting at a key tradeshow – Vitafoods 2023 in Geneva

Eevia Health Plc (”Eevia” or ”The Company”) is promoting its products and value proposition by exhibiting at Vitafoods 2023, a key nutraceutical tradeshow in Geneva, Switzerland between 9 – 11 May 2023Eevia is represented by its sales team and a stand at the annual Vitafoods tradeshow , which is held in Geneva in the second week of May every year. Vitafoods is a key event in the global nutraceutical industry, attracting over 15,000 industry experts from over 130 countries every year. The show has built its leading position since 1997 by maintaining

BlueNord Announce First Quarter 2023 Results

Oslo, 10 May 2023: BlueNord ASA ("BlueNord" or the "Company") today published its first quarter 2023 results. The first quarter of the year delivered excellent operational performance and strong cash generative financial results.  Highlights: · First quarter net hydrocarbon production of 26.6 mboepd, above quarterly guidance · Strong underlying reservoir performance where natural decline is mitigated by high level of well activities · Revenues of USD 221 million compared to USD 179 million in same quarter in 2022 · EBITDA in Q1 of USD 122 million, versus USD 107 million in

Investor supports Sobi’s tender offer for CTI BioPharma and undertakes to subscribe for its pro rata share in Sobi’s rights issue

Sobi has today communicated its offer to acquire CTI BioPharma (CTI), a US listed company within hematology, for USD 9.10 per share, equivalent to an enterprise value of USD 1.7bn and to carry out a rights issue with preferential rights for existing shareholders to partially finance the acquisition. Investor AB, Sobi’s largest owner, with an ownership of 34.7 per cent of the capital and votes, supports the bid and has undertaken to subscribe for its pro rata share in the rights issue corresponding to SEK 2.9bn. “Investor was instrumental in the creation of Sobi close to 15 years ago.

Interim Report 3 months - 1 January-31 March 2023

FIRST QUARTER (1 JAN-31 MAR 2023) · Net sales declined by 12 percent to MSEK 1,505 (1,716), of which currency-adjusted sales declined 15 percent. · Operating profit before depreciation and amortisation (EBITDA) excluding non-recurring items of MSEK 0 (-11) amounted to MSEK 138 (168) 1). · Operating profit amounted to MSEK 70 (86) 1), corresponding to an operating margin of 4.7 percent (5.0). · Profit after financial items totalled MSEK 57 (80). · Profit after tax amounted to MSEK 41 (57). · Earnings per share before and after dilution totalled SEK 0.15 (0.25). 2) ·

Camurus’ Interim Report January-March 2023

“A strong quarter with solid organic growth, both top and bottom line” Summary first quarter 2023 January – March · Total revenues amounted to SEK 284 (220) million, an increase of 29% (24% at CER[1]), whereof product sales were SEK 282 (202) million, an increase of 40% (35% at CER[1]) · Revenue and product sales increased 6% compared to previous quarter · Operating result was SEK 74 (5) million, an increase of SEK 69 million · Cash position at the end of the quarter was SEK 586 (400) million, an increase of SEK 186 million (47%) · Number of patients treated with

Sobi to acquire CTI BioPharma Corp. enhancing Sobi’s position in rare haematology

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION. THIS PRESS RELEASE DOES NOT CONSTITUTE AN OFFER OF OR THE SOLICITATION OF AN OFFER TO BUY SECURITIES IN ANY JURISDICTION. Swedish Orphan Biovitrum AB (publ) (Sobi®) (STO:SOBI) today announced that it has entered into an agreement and plan of merger with CTI BioPharma Corp. (CTI) under which Sobi has agreed to acquire CTI, a biopharmaceutical company focused on blood related cancers and

There are no items matching the current filter
There are no more items matching the current filter
Back to top